Health Canada
Special Access Program

Through Health Canada’s Special Access Program (SAP), health care professionals may request access to non-marketed drugs to treat patients with serious or life-threatening conditions. Access to these drugs is only considered when conventional therapies have failed, are unsuitable or are unavailable.

SAP authorization allows a manufacturer to sell a drug that has not been approved for sale in Canada. Drugs considered for release under SAP include pharmaceutical, biologic, and radiopharmaceutical products.

To learn more about how to request special access to an unapproved drug, visit:

If you have questions about the SAP, send us an email at